Amnio Tri-Core
A three-layer amniotic membrane allograft. It was studied with weekly application after Mohs micrographic surgery in a 46-patient, 10-site retrospective series.
Common in: Mohs & dermatologic surgery · Wound care centers
Key facts
- HCPCS Q4295; billed per sq cm
- Dry storage
- Three-layer construction
Downloads & documents
Specifications
| HCPCS | Q4295 |
|---|---|
| Construction | Three-layer amniotic membrane |
From Stability Biologics materials. Confirm current specs and IFU before use.
Studies & evidence
Tap a study for the findings, limits, and source.
RetrospectiveStability Biologics
Weekly Amnio Tri-Core application after Mohs micrographic surgery
46 patients, 10 sites
Mean wound volume fell from 2.77 cm³ to 0.35 cm³ (p<0.0001). Mean wound-area reduction was 84.4% (median 91.9%), and mean time to complete healing was 8.5 weeks (median 6 weeks).
Limits: Retrospective and uncontrolled. Healing time varied by site (ear 4.7 wks, forehead 21.4 wks).
Peer-reviewedStability Biologics
Placental allograft vs. flap or full-thickness graft after Mohs surgery
286 Mohs defects
Compared with flap or full-thickness graft repair, placental allograft repair had about 12× lower adjusted odds of infection or reintervention (adjusted OR 11.71) and about 19× lower adjusted odds of poor scar cosmesis or revision (adjusted OR 18.76), with equivalent time to wound closure.
Limits: Observational design. Looks at placental allografts as a class, not AmnioCore specifically.
About Stability Biologics
Vertically integrated tissue company founded in 2010 in San Antonio, TX. FDA-registered under 21 CFR Part 1271 and AATB-accredited. Makes the AmnioCore family and bone graft products.
Related products
All Wound & SurgicalAmnio Quad-Core
A four-layer amniotic membrane allograft for cases that need a thicker graft.
AmnioCore Pro (Amnion / Chorion)
Amnion/chorion membrane allografts in dual-layer and three-layer (amnion/chorion/amnion) versions.